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Background
Brazil may harbor the largest absolute number of
HTLV-1-infected individuals worldwide. The current
HTLV diagnosis is based mainly on antibodies detection.
However, these tests exhibit high proportion of indeter-
minate results. Several real-time PCR techniques have
been developed for the detection of HTLV-1/2. How-
ever, up to day the major drawbacks of HTLV-1/2 mole-
cular diagnosis are the lack of standard molecular tests
and the absence of suitable internal amplification con-
trol (IAC). The aim of this study was to develop a mul-
tiplex qualitative real-time PCR for the simultaneous
detection and discrimination of HTLV-1/2 and to design
an IAC for reaction monitoring.
Methods
After multiple sequence alignments of the full genomes
of HTLV-1/2 subtypes, a conserved tax region was cho-
sen for the design of specific primers and probes. The
IAC was generated after the annealing of synthetic
nucleotide sequences and cloned into TOPO TA
® vec-
tor. MT-2 and Gu cell lines were used as positive con-
trols for HTLV-1 and HTLV-2, respectively.
Results
The developed multiplex real-time reaction detected
both HTLV-1 and HTLV-2 (105 to 101 copies/reaction)
at the presence of IAC in the same reaction. Analytical
sensitivity was 1.2 copies/reaction for HTLV-1 and 19.1
copies/reaction for HTLV-2. The analytical sensitivity
analysis was performed in singleplex format.
Conclusion
The detection of HTLV-1/2 and IAC by multiplex real-
time PCR was efficient. The developed IAC is suitable
for the molecular diagnosis and its presence ensures
that the negative results are not due to failure in pre-
PCR procedures.
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